- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2017
- Public Summary Document (PSD) November 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2017 PBAC Meeting - Word
Pomalidomide – November 2017
Pomalidomide: Capsule 3 mg, Capsule 4 mg; Pomalyst®
Last updated
2 March 2018